Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson’s Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway

Background/Aims: Parkinson’s disease (PD) is a common neurodegenerative disease in the old population, characterized by dopaminergic neuron loss, inflammation and oxidative stress injury in the substantia nigra. Glaucocalyxin B (GLB), an ent-kauranoid diterpenoid isolated from Rabdosia japonica, has...

Descripció completa

Dades bibliogràfiques

Autors principals:	Wei Xu, Deyu Zheng, Yuanyuan Liu, Ji Li, Li Yang, Xiuli Shang
Format:	Artigo
Idioma:	Inglês
Publicat:	Cell Physiol Biochem Press GmbH & Co KG 2017-12-01
Col·lecció:	Cellular Physiology and Biochemistry
Matèries:	Parkinson’s disease Glaucocalyxin B Toll-like receptor Nuclear factor kappa B Nuclear factor erythroid 2-related factor 2
Accés en línia:	https://www.karger.com/Article/FullText/485947
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!